相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antibody mimetic drug conjugate manufactured by high-yield Escherichia coli expression and non-covalent binding system
Kenzo Yamatsugu et al.
PROTEIN EXPRESSION AND PURIFICATION (2022)
Pathological complete remission of relapsed tumor by photo-activating antibody-mimetic drug conjugate treatment
Yudai Kaneko et al.
CANCER SCIENCE (2022)
Novel small 99mTc-labeled affibody molecular probe for PD-L1 receptor imaging
Zhigang Liang et al.
FRONTIERS IN ONCOLOGY (2022)
Duocarmycin-based antibody-drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progress
Hang-Ping Yao et al.
DRUG DISCOVERY TODAY (2021)
Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy
Sandeep Surendra Panikar et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer
Eric Chabrol et al.
PROTEIN SCIENCE (2021)
TGFβ receptor endocytosis and Smad signaling require synaptojanin1, PI3K-C2α-, and INPP4B-mediated phosphoinositide conversions
Sho Aki et al.
MOLECULAR BIOLOGY OF THE CELL (2020)
Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells
Dominik P. Buser et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
Total Synthesis of (+)-CC-1065 Utilizing Ring Expansion Reaction of Benzocyclobutenone Oxime Sulfonate
Taku Imaizumi et al.
ORGANIC LETTERS (2019)
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
Anna Wolska-Washer et al.
DRUG SAFETY (2019)
Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985)
Zhuyu Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Cupid and Psyche system for the diagnosis and treatment of advanced cancer
Akira Sugiyama et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2019)
Nanobody: outstanding features for diagnostic and therapeutic applications
J. -Pablo Salvador et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)
Variable Heavy Chain Domain Derived from a Cell-Penetrating Anti-DNA Monoclonal Antibody for the Intracellular Delivery of Biomolecules
Sun-Woo Im et al.
IMMUNOLOGICAL INVESTIGATIONS (2017)
A camelid nanobody against EGFR was easily obtained through refolding of inclusion body expressed in Escherichia coli
Li Xu et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2017)
131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment
Matthias D'Huyvetter et al.
CLINICAL CANCER RESEARCH (2017)
SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression
Jonathan Black et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Affibody-mediated PET imaging of HER3 expression in malignant tumours
Maria Rosestedt et al.
SCIENTIFIC REPORTS (2015)
Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
J. Lofblom et al.
FEBS LETTERS (2010)
Yatakemycin: total synthesis, DNA alkylation, and biological properties
Mark S. Tichenor et al.
NATURAL PRODUCT REPORTS (2008)
Total synthesis of (+)-yatakemycin
Kentaro Okano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Formation of disulfide bonds in proteins and peptides
G Bulaj
BIOTECHNOLOGY ADVANCES (2005)
Total synthesis of the duocarmycins
K Yamada et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Phase II trial of KW2189 in patients with advanced malignant melanoma
SN Markovic et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
分享论文
